Morris Sherman
University of Toronto
Toronto
Canada
Name/email consistency: high
- Modern approach to hepatocellular carcinoma. Sherman, M. Curr. Gastroenterol. Rep (2011)
 - Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Sherman, M. Semin. Liver Dis. (2010)
 - The resurrection of alphafetoprotein. Sherman, M. J. Hepatol. (2010)
 - Hepatocellular carcinoma: New and emerging risks. Sherman, M. Dig. Liver. Dis (2010)
 - Serological surveillance for hepatocellular carcinoma: time to quit. Sherman, M. J. Hepatol. (2010)
 - Vinyl chloride and the liver. Sherman, M. J. Hepatol. (2009)
 - Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks. Sherman, M., Yurdaydin, C., Simsek, H., Silva, M., Liaw, Y.F., Rustgi, V.K., Sette, H., Tsai, N., Tenney, D.J., Vaughan, J., Kreter, B., Hindes, R. Hepatology (2008)
 - Surveillance for hepatocellular carcinoma and early diagnosis. Sherman, M. Clin. Liver. Dis (2007)
 - Management of chronic hepatitis B: consensus guidelines. Sherman, M., Shafran, S., Burak, K., Doucette, K., Wong, W., Girgrah, N., Yoshida, E., Renner, E., Wong, P., Deschênes, M. Can. J. Gastroenterol. (2007)
 - Management of chronic hepatitis C: consensus guidelines. Sherman, M., Shafran, S., Burak, K., Doucette, K., Wong, W., Girgrah, N., Yoshida, E., Renner, E., Wong, P., Deschênes, M. Can. J. Gastroenterol. (2007)
 - What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma?. Sherman, M. Nature Clinical Practice. Gastroenterology & Hepatology (2006)
 - Personal view: the management of chronic hepatitis B infection. Sherman, M. Aliment. Pharmacol. Ther. (2006)
 - Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Sherman, M., Yoshida, E.M., Deschenes, M., Krajden, M., Bain, V.G., Peltekian, K., Anderson, F., Kaita, K., Simonyi, S., Balshaw, R., Lee, S.S. Gut (2006)
 - Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin. Sherman, M., Cohen, L., Cooper, M.A., Elkashab, M., Feinman, V., Fletcher, D., Girgrah, N., Heathcote, J., Levstik, M., McNaull, W.B., Wong, D., Wong, F., Yim, C. Can. J. Gastroenterol. (2006)
 - Why adefovir is not yet available in Canada. Sherman, M. Can. J. Gastroenterol. (2006)
 - Chronic hepatitis C and screening for hepatocellular carcinoma. Sherman, M. Clin. Liver. Dis (2006)
 - Approaches to the diagnosis of hepatocellular carcinoma. Sherman, M. Curr. Gastroenterol. Rep (2005)
 - Screening for hepatocellular carcinoma. Sherman, M. Best. Pract. Res. Clin. Gastroenterol (2005)
 - Hepatocellular carcinoma: epidemiology, risk factors, and screening. Sherman, M. Semin. Liver Dis. (2005)
 - Predicting survival in hepatitis B. Sherman, M. Gut (2005)
 - AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. Sherman, M., Klein, A. Hepatology (2004)
 - The management of chronic viral hepatitis: a Canadian consensus conference 2004. Sherman, M., Bain, V., Villeneuve, J.P., Myers, R.P., Cooper, C., Martin, S., Lowe, C. Can. J. Gastroenterol. (2004)
 









